Type 2 Diabetes

Researchers in Taiwan report that type 2 diabetes is independently associated with increased risk of peptic ulcer bleeding.

The American Diabetes Association revised Standards of Medical Care for patients with diabetes include several changes in recommendations regarding testing and treatment goals.

Results from the RELAX-AHF show serelaxin reduces cardiovascular deaths and improves symptoms in patients with heart failure.

Results from a sub-study of the Trial to Assess Chelation Therapy (TACT) that focused on quality of life issues in patients who had previously suffered a heart attack and were treated with chelation therapy reveal no improvements in these patients' quality of life.

Increasing numbers of people are on kidney transplant waiting lists. However, the number of potential living donors may shrink as more Americans qualify as pre-diabetic, making them less than ideal donor candidates.

New research suggests that Interpersonal Psychotherapy may be an effective option for treating major depression in patients with type 2 diabetes mellitus.

Promising initial results from a Phase 3 trial of DiaPep277 have raised hopes that an alternative to insulin may soon be available to treat type 1 diabetes.

According to a nationwide review of data from the in-patient register, 31 of the 33 autoimmune diseases studied were associated with an increased risk of pulmonary embolism (a blood clot on the lung), including type 1 diabetes.

In honor of Diabetes Awareness Month, the ADA put together video clips of health care professionals pledging to stop diabetes.

Scientists at Stanford University have identified a pathway responsible for age-related beta cell decline.

A recent study has found that it can be very difficult for children who suffer from both type 1 diabetes and asthma to regulate their blood sugar.

Two drugs which treat type 2 diabetes could lead to a substantially increased risk of pancreatitis and pancreatic cancer.

A new study has found that increasing muscle mass may also help lower the risk of the metabolic disease.

A recent study has discovered that early treatment with the diabetes drug metformin may prevent or delay the development of PCOS in young girls.

Real-time blood sugar and insulin infusion data displayed in the electronic medical record allows physicians to tailor treatment and get more patients to goal.

Dr. Trevor Orchard previews what he will be discussing during his presentation on cardiovascular disease in patients with type 1 diabetes at the ADA meeting.

Irregular periods in teenage girls may be linked to obesity, diabetes, reproductive issues, and heart disease.

The brain's hypothalamus plays a key role in obesity and one of its major complications – type 2 diabetes.

A new study of older diabetes patients has found that the very lowest blood sugar levels were associated with a small but significant increased risk of death.

A growing body of research suggests that caffeine may contribute to the development and poor control of type 2 diabetes.

Advanced glycation end products may explain why some diabetics live free from eye, kidney, nerve, and cardiovascular complications for more than 5 decades.

Prediabetic rats treated with sitagliptin not only experienced lower glucagon and higher insulin levels, but a redistribution of body fat.

Nearly 30 million new patients will be diagnosed with diabetes by 2025 at a cost of $514 billion. Can we stop the prediction from becoming reality?

A blood screen testing for elevations in five amino acids can identify individuals at risk of developing type 2 diabetes a decade prior to symptom onset.

Patients with type 1 diabetes are vulnerable to autoimmune heart disease and a missed "training regimen" in the thymus explains why.